Contact System Activation and Bradykinin Generation in Angioedema: Laboratory Assessment and Biomarker Utilization.

Autor: Christiansen SC; Department of Medicine, University of California San Diego, 9500 Gilman Drive, Mail Code 0732, La Jolla, CA 92093, USA., Zuraw BL; Department of Medicine, University of California San Diego, 9500 Gilman Drive, Mail Code 0732, La Jolla, CA 92093, USA; Medicine Service, San Diego Veterans Administration Healthcare System, 3350 La Jolla Village Drive, San Diego, CA 92161, USA. Electronic address: bzuraw@ucsd.edu.

Publikováno v: Immunology and allergy clinics of North America [Immunol Allergy Clin North Am] 2024 Aug; Vol. 44 (3), pp. 543-560. Date of Electronic Publication: 2024 May 18.

A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema.

Autor: Petersen RS; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Bordone L; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Riedl MA; University of California San Diego, La Jolla, California, USA., Tachdjian R; Department of Pediatrics, University of California, Los Angeles, California, USA.; Providence Saint John's Health Center, Santa Monica, California, USA., Craig TJ; Department of Medicine, Pediatrics, and Biomedical Sciences, Pennsylvania State University, Hershey, Pennsylvania, USA.; Vinmec International Hospital, Times City, Hanoi, Vietnam., Lumry WR; Allergy and Asthma Research Associates Research Center, Dallas, Texas, USA., Manning ME; Medical Research of Arizona, Scottsdale, Arizona, USA., Bernstein JA; Department of Internal Medicine, University of Cincinnati College of Medicine, and Bernstein Clinical Research Center, Cincinnati, Ohio, USA., Raasch J; Midwest Immunology Clinic, Plymouth, Minnesota, USA., Zuraw BL; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, University of California San Diego, La Jolla, California, USA., Deng Y; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Newman KB; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Alexander VJ; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Lui C; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Schneider E; Ionis Pharmaceuticals, Inc., Carlsbad, California, USA., Cohn DM; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.

Publikováno v: Allergy [Allergy] 2024 Mar; Vol. 79 (3), pp. 724-734. Date of Electronic Publication: 2023 Nov 27.

Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD.

Autor: Badrani JH; Section of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif; Veterans Affairs San Diego Healthcare System, La Jolla, Calif., Cavagnero K; Section of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif., Eastman JJ; Section of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif., Kim AS; Section of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif., Strohm A; Section of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif; Veterans Affairs San Diego Healthcare System, La Jolla, Calif., Yan C; Department of Otolaryngology, University of California, San Diego, Calif., Deconde A; Department of Otolaryngology, University of California, San Diego, Calif., Zuraw BL; Section of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif; Veterans Affairs San Diego Healthcare System, La Jolla, Calif., White AA; Divison of Allergy, Asthma and Immunology, Scripps Clinic, La Jolla, Calif., Christiansen SC; Section of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif., Doherty TA; Section of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif; Veterans Affairs San Diego Healthcare System, La Jolla, Calif. Electronic address: tdoherty@health.ucsd.edu.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Nov; Vol. 152 (5), pp. 1330-1335.e1. Date of Electronic Publication: 2023 Aug 03.

Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being.

Autor: Christiansen SC; From the Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, San Diego, California, and., Lopes Veronez C; From the Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, San Diego, California, and., Smith TD; From the Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, San Diego, California, and., Riedl MA; From the Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, San Diego, California, and., Zuraw BL; From the Division of Rheumatology, Allergy and Immunology, Department of Medicine, University of California San Diego, San Diego, California, and.

Publikováno v: Allergy and asthma proceedings [Allergy Asthma Proc] 2023 Mar 01; Vol. 44 (2), pp. 115-121.

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

Autor: Longhurst, H, Cicardi, M, Craig, T, Bork, K, Grattan, C, Baker, J, Li, HH, Reshef, A, Bonner, J, Bernstein, JA, Anderson, J, Lumry, WR, Farkas, H, Katelaris, CH, Sussman, GL, Jacobs, J, Riedl, M, Manning, ME, Hebert, J, Keith, PK, Kivity, S, Neri, S, Levy, DS, Baeza, ML, Nathan, R, Schwartz, LB, Caballero, T, Yang, W, Crisan, I, Hernandez, MD, Hussain, I, Tarzi, M, Ritchie, B, Kralickova, P, Guilarte, M, Rehman, SM, Banerji, A, Gower, RG, Bensen-Kennedy, D, Edelman, J, Feuersenger, H, Lawo, JP, Machnig, T, Pawaskar, D, Pragst, I, Zuraw, BL, COMPACT Investigators

Publikováno v: NEW ENGLAND JOURNAL OF MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Scientia

Prevenció; Atac d'angioedema; Inhibidor C1 Prevención; Ataque de angioedema; Inhibidor C1 Prevention; Angioedema attack; C1 inhibitor BACKGROUND: Hereditary angioedema is a disabling, potentially fatal condition caused by deficiency (type I) or dys

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef37114d60fc174570de4929b77385e0
https://doi.org/10.1056/nejmoa1613627